-
Wednesday 7 April marks World Health Day, a day organised by the World Health Organization (WHO) to highlight a particular global health issue. This year, it aims to spotlight health equity.
Health equity is the absence of avoidable and unfair differences in health. The COVID-19 pandemic and its uneven impacts worldwide has brought attention to...
7 April 2021
-
Cochrane community contributes to update to the PRISMA statement. PRISMA is an evidence-based minimum set of items for reporting in systematic reviews and meta-analyses. PRISMA primarily focuses on the reporting of reviews evaluating the effects of interventions, but can also be used as a basis for reporting systematic reviews with objectives...
7 April 2021
-
Interview with Heather Tubwon, the artist that created the new limited edition designs in the Cochrane store celebrating Anne Anderson and our diverse community.
The global Cochrane community are participating in a virtual walk and raising money for the annual Anne Anderson Award, which is given to a Cochrane member who has contributed...
6 April 2021
-
In March 2020, Cochrane Australia convened the National COVID-19 Clinical Evidence Taskforce - bringing together leading health researchers, experts and organisations from across the country.
Since then, over 240 members have worked around the clock to deliver living clinical guidelines and flowcharts for frontline health workers. The...
1 April 2021
-
Cochrane provides high-quality, relevant and up-to-date synthesized research evidence to inform health decisions. This page highlights the many ways that Cochrane has successfully responded to COVID-19 around the world. Click on any of the case studies below to find out more, and check back often as we continuously add and update new stories....
1 April 2021
-
Cochrane Austria, together with TranspariMED and Transparency International Austria, has recently published a report on clinical trial transparency in Austria, which provides an update on figures released one year ago.
The report uses data from the EU Trials Tracker to summarise the clinical drug trial reporting rates of the 14 largest sponsors in...
30 März 2021
-
Register for the 'A day with... Statistics Methods Group’ which is taking place on 11 May 2021.
This is part of a series of virtual events from Cochrane Training for anyone interested in systematic review methodology and the work of Cochrane Methods Groups. Whether you are new to systematic review methodology or an advanced-level learner, these...
29 März 2021
-
In the Medical Degree Program at Lund University, Sweden, a new Scientific Scholarship theme has been implemented, including evidence-based medicine (EBM), as the application of scientific scholarship in EBM is a core aspect of medical education. Throughout the program, scientific scholarship and EBM are supported by multifaceted learning...
26 März 2021
-
During the past 12 months chloroquine and hydroxychloroquine have been touted as cures for COVID-19 and introduced into Covid-19 treatment protocols. This has led to increases in demand, leaving some rheumatoid arthritis and lupus patients deprived of effective treatments.
A newly published Cochrane Library Editorial explores the story of the...
25 März 2021
-
COVID-19 is an infectious respiratory disease caused by a coronavirus called SARS-CoV-2. If the infection becomes severe, people may need intensive care and support in hospital, including mechanical ventilation.
Drugs used for other diseases were tried out in COVID-19, and this included chloroquine, used for malaria; and...
25 März 2021
-
Watch Cochrane US Senior Officer, Tiffany Duque, as the featured guest on the Addictive Brain videocast. Tiffany spoke to Dr. Chinmaya Sadangi for the session called "Interview with a Scientist."
The Addictive Brain is an online community aiming at bridging the gap between science and the world in general. Their audience is mostly non-...
24 März 2021
-
Cochrane is made up of 11,000 members and over 67,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.
Getting involved in Cochrane’s work means becoming part of a global...
22 März 2021
-
Mindfulness has been growing in popularity across the globe over the past decade and is increasingly the subject of scientific research into the benefits it may deliver. In 2020, six students from Melbourne’s Monash University sought to better understand if and how mindfulness practice could help fellow medical students and junior doctors deal...
18 März 2021
-
This recently published Cochrane review examines the effects of a class of treatments on people with COVID-19.
Treating COVID-19 with tocilizumab (a medicine that blocks interleukin-6) reduces the numbers of people who die within 28 days of treatment, and probably results in fewer serious unwanted effects than placebo treatment.
Studies of other...
18 März 2021
-
Cochrane has signed a World Health Organization (WHO) Declaration that calls for a more equitable rollout of COVID-19 vaccines.
While several countries currently have vaccination programmes up and running, the global distribution of vaccines has so far been unequal. Many low- and middle-income countries are yet to receive any doses and...
17 März 2021
-
17 März 2021
-
Cochrane Library Special Collections provide a round-up of up-to-date Cochrane evidence on a specific topic. This Special Collection provides evidence in several key clinical priority areas for brain tumour research. The reviews in this Collection provide evidence towards clinical priority areas for research, and their funding, and therefore, are...
17 März 2021
-
Dear Colleagues,
We would like to share more information on the forthcoming virtual session on Monday 22 March 2021 (Tuesday 23 March in some timezones).
This free, online event open to everyone in Cochrane will give members the opportunity to hear updates about key organizational priorities for 2021 and beyond. So far, more than 200 people have...
16 März 2021
-
Updated Review: How accurate is chest imaging for diagnosing COVID-19?
Why is this question important?
People with suspected COVID-19 need to know quickly whether they are infected, so they can receive appropriate treatment, self-isolate, and inform close contacts.
Currently, formal diagnosis of COVID-19 requires a laboratory test (RT-PCR)...
16 März 2021
-
15 März 2021
Wednesday 7 April marks World Health Day, a day organised by the World Health Organization (WHO) to highlight a particular global health issue. This year, it aims to spotlight health equity. Health equity is the absence of avoidable and unfair differences in health. The COVID-19 pandemic and its uneven impacts worldwide has brought attention to...7 April 2021
Cochrane community contributes to update to the PRISMA statement. PRISMA is an evidence-based minimum set of items for reporting in systematic reviews and meta-analyses. PRISMA primarily focuses on the reporting of reviews evaluating the effects of interventions, but can also be used as a basis for reporting systematic reviews with objectives...7 April 2021
Interview with Heather Tubwon, the artist that created the new limited edition designs in the Cochrane store celebrating Anne Anderson and our diverse community. The global Cochrane community are participating in a virtual walk and raising money for the annual Anne Anderson Award, which is given to a Cochrane member who has contributed...6 April 2021
In March 2020, Cochrane Australia convened the National COVID-19 Clinical Evidence Taskforce - bringing together leading health researchers, experts and organisations from across the country.
Cochrane provides high-quality, relevant and up-to-date synthesized research evidence to inform health decisions. This page highlights the many ways that Cochrane has successfully responded to COVID-19 around the world. Click on any of the case studies below to find out more, and check back often as we continuously add and update new stories....1 April 2021
Cochrane Austria, together with TranspariMED and Transparency International Austria, has recently published a report on clinical trial transparency in Austria, which provides an update on figures released one year ago. The report uses data from the EU Trials Tracker to summarise the clinical drug trial reporting rates of the 14 largest sponsors in...30 März 2021
Register for the 'A day with... Statistics Methods Group’ which is taking place on 11 May 2021. This is part of a series of virtual events from Cochrane Training for anyone interested in systematic review methodology and the work of Cochrane Methods Groups. Whether you are new to systematic review methodology or an advanced-level learner, these...29 März 2021
In the Medical Degree Program at Lund University, Sweden, a new Scientific Scholarship theme has been implemented, including evidence-based medicine (EBM), as the application of scientific scholarship in EBM is a core aspect of medical education. Throughout the program, scientific scholarship and EBM are supported by multifaceted learning...26 März 2021
During the past 12 months chloroquine and hydroxychloroquine have been touted as cures for COVID-19 and introduced into Covid-19 treatment protocols. This has led to increases in demand, leaving some rheumatoid arthritis and lupus patients deprived of effective treatments. A newly published Cochrane Library Editorial explores the story of the...25 März 2021
COVID-19 is an infectious respiratory disease caused by a coronavirus called SARS-CoV-2. If the infection becomes severe, people may need intensive care and support in hospital, including mechanical ventilation.
Watch Cochrane US Senior Officer, Tiffany Duque, as the featured guest on the Addictive Brain videocast. Tiffany spoke to Dr. Chinmaya Sadangi for the session called "Interview with a Scientist." The Addictive Brain is an online community aiming at bridging the gap between science and the world in general. Their audience is mostly non-...24 März 2021
Cochrane is made up of 11,000 members and over 67,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere. Getting involved in Cochrane’s work means becoming part of a global...22 März 2021
Mindfulness has been growing in popularity across the globe over the past decade and is increasingly the subject of scientific research into the benefits it may deliver. In 2020, six students from Melbourne’s Monash University sought to better understand if and how mindfulness practice could help fellow medical students and junior doctors deal...18 März 2021
This recently published Cochrane review examines the effects of a class of treatments on people with COVID-19. Treating COVID-19 with tocilizumab (a medicine that blocks interleukin-6) reduces the numbers of people who die within 28 days of treatment, and probably results in fewer serious unwanted effects than placebo treatment. Studies of other...18 März 2021
Cochrane has signed a World Health Organization (WHO) Declaration that calls for a more equitable rollout of COVID-19 vaccines.
17 März 2021
Cochrane Library Special Collections provide a round-up of up-to-date Cochrane evidence on a specific topic. This Special Collection provides evidence in several key clinical priority areas for brain tumour research. The reviews in this Collection provide evidence towards clinical priority areas for research, and their funding, and therefore, are...17 März 2021
Dear Colleagues, We would like to share more information on the forthcoming virtual session on Monday 22 March 2021 (Tuesday 23 March in some timezones). This free, online event open to everyone in Cochrane will give members the opportunity to hear updates about key organizational priorities for 2021 and beyond. So far, more than 200 people have...16 März 2021
Updated Review: How accurate is chest imaging for diagnosing COVID-19? Why is this question important?
15 März 2021